Loading...
Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom Onset
BACKGROUND: The aim of the present study was to investigate the efficacy and safety of antiplatelet (aspirin plus cilostazol) dual therapy for patients with noncardioembolic stroke within 48 hours of symptom onset. METHODS AND RESULTS: The ADS (Acute Aspirin Plus Cilostazol Dual Therapy for Non‐Card...
Na minha lista:
| Udgivet i: | J Am Heart Assoc |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6761671/ https://ncbi.nlm.nih.gov/pubmed/31347430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.012652 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|